Table 4 Days survived after CAH
From: Administration of bisphosphonate for hypercalcemia associated with oral cancer
Characteristics | median (min. ~max.) | p value* |
|---|---|---|
Gender | ||
   Male (n = 10) | 38 (13 ~152) | 0.117 |
   Female (n = 6) | 22 (3 ~46) | |
Age | ||
   60 > (n = 8) | 40.5 (13 ~152) | 0.138 |
   60 ≦(n = 8) | 27 (3 ~69) | |
Primary site | ||
   Tongue (n = 6) | 32 (13 ~46) | 0.479 |
   Others (n = 10) | 31 (3 ~152) | |
Time from tumor diagnosis to CAH | ||
   Within 1 year (n = 9) | 43 (10~152) | 0.139 |
   Over 1 year (n = 7) | 27 (3~46) | |
WBC (x 1000/m3) at diagnosis of CAH | ||
   10 > (n = 10) | 38 (17 ~152) | 0.103 |
   10 ≦(n = 6) | 20 (3 ~46) | |
Hb(g/dl) at diagnosis of CAH | ||
   10.9 > (n = 8) | 41.5 (17 ~152) | 0.092 |
   10.9 ≦(n = 8) | 22 (3 ~46) | |
Serum ALP (IU/dl) at diagnosis of CAH | ||
   300 > (n = 6) | 51 (27 ~152) | 0.118 |
   300 ≦(n = 10) | 28 (3 ~46) | |
Serum CRP (mg/dl) at diagnosis of CAH | ||
   4.0 > (n = 8) | 38.5 (27 ~152) | 0.058 |
   4.0 ≦(n = 8) | 22 (3 ~46) | |
Treatment with BP | ||
   Yes (n = 9) | 44 (13 ~152) | 0.015 |
   No (n = 7) | 27 (3 ~43) | |
Treatment with Anticancer agent | ||
   Yes (n = 5) | 33 (17 ~69) | 0.868 |
   No (n = 11) | 29 (3 ~152) | |